PCIBo — PCI Biotech Holding ASA Share News
0.000.00%
Last trade - 00:00- NOK6.07m
- -NOK7.27m
- NOK6.74m
Brief: PCI Biotech: Independent evaluation confirms promising signs of efficacy in Phase I/II bile duct cancer study
Brief: PCI Biotech and BioNTech start preclinical research collaboration
Brief: PCI Biotech Q2 operating loss widens to NOK 9.3 million
Brief: PCI Biotech: Orphan Drug Designation for fimaporfin
Brief: PCI Biotech: Positive opinion for Orphan Drug Designation for fimaporfin
Brief: PCI Biotech: Pre-clinical research collaboration with large pharma co extended
Brief: PCI Biotech Q1 operating loss narrows to NOK 7.3 million
Brief: PCI Biotech Q4 operating loss narrows to NOK 8.5 million
Brief: PCI Biotech and Ultimovacs initiates preclinical research collaboration
Brief: PCI Biotech completes dose escalation in study with fimaporfin
Brief: PCI Biotech: Erling Øverland not to stand for re-election as chairman
Brief: PCI Biotech Q3 operating loss widens to NOK 9.4 million
Brief: PCI Biotech in pre-clinical research collaboration with large pharma company
Brief: PCI Biotech Holding successful completion of the third dose cohort
Brief: PCI Biotech Q1 operating loss narrowing to NOK 7.7 million
Brief: PCI Biotech initiates preclinical research collaboration in siRNA therapeutics
Brief: PCI Biotech Holding Q4 operating loss widens to NOK 10.3 million
Brief: PCI Biotech Holding: Completion of the third group of the ENHANCE study
Brief: PCI Biotech Holding: Erik Must and associates own 14.13 pct in PCI Biotech Holding